Structure Therapeutics Inc. (GPCR)
| Previous Close | 34.01 |
| Open | 34.55 |
| Bid | 34.14 x 100 |
| Ask | 34.55 x 100 |
| Day's Range | 33.78 - 35.28 |
| 52 Week Range | 26.61 - 66.38 |
| Volume | |
| Avg. Volume | 735,809 |
| Market Cap | 1.973B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
Structure Therapeutics Inc. (GPCR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
We recently compiled a list of the 12 NASDAQ Stocks with Biggest Upside Potential According to Analysts. In this article, we are going to take a look at where Structure Therapeutics Inc. (NASDAQ:GPCR) stands against the other NASDAQ stocks. Potomac Wealth Advisors president Mark Avallone joined CNBC’s ‘The Exchange’ on November 16 to discuss where he […]
- BioPharma Dive
GPCR drugmaker Septerna amasses $288M in IPO
Septerna upped the size of its offering twice before pricing a stock sale that raised funds for its lead candidate, a treatment for hypoparathyroidism now in Phase 1 testing.
- Insider Monkey
Structure Therapeutics (GPCR): Innovating Oral Therapies for Obesity and Diabetes
We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a look at where Structure Therapeutics (NASDAQ:GPCR) stands against other biggest stocks with negative beta to consider. Beta is a measureament of market risk or volatility that indicates how much the price of […]
